Research Groups and R&D Platforms: Autoimmune diseases
![Picture of Laura Elo](https://drugdevelopment.fi/wp-content/uploads/2017/05/Elo_Laura-6.jpg)
Research Group:
Computational Biomedicine and Bioinformatics
Laura Elo
laura.elo[at]utu.fi
Turku Bioscience Centre,
University of Turku
Autoimmune diseases, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Diabetes, Diagnostics, Epigenomics, Genomics, Imaging, Machine learning, Metabolic diseases, Molecular diagnostics, Next-generation sequencing, Pattern recognition, Personalized medicine, Proteomics, Systems Biology, Target discovery
![](https://drugdevelopment.fi/wp-content/uploads/2017/06/Wittfooth_Saara-14.jpg)
Research Group:
Cardiac Biomarkers
Saara Wittfooth
saara.wittfooth@utu.fi
Department of Life Technologies,
University of Turku
Ageing-related diseases, Antibodies, Assay development, Autoimmune diseases, Biomarker, Biotechnology, Cardiovascular diseases, Clinical Chemistry, Clinical Medicine, In Vitro Diagnostics, Inflammation, Metabolic diseases, Obesity
![](https://drugdevelopment.fi/wp-content/uploads/2017/05/Hanninen_Arno.jpg)
Research Group:
Enzymatic activity of gut bacteria in infancy and its impact on healthy microbiome
Arno Hänninen
arno.hanninen[at]utu.fi
Institute of Biomedicine,
University of Turku
Autoimmune diseases, Bacteriology, Bioinformatics, Biomarker, Clinical Medicine, Data mining, Diabetes, Immunology, In Vitro Diagnostics, Inflammation, Obesity, Personalized medicine
![](https://drugdevelopment.fi/wp-content/uploads/2017/05/Jalkanen_Sirpa-7.jpg)
Research Group:
New tools to target harmful inflammations and cancer
Sirpa Jalkanen
sirjal[at]utu.fi
Institute of Biomedicine,
University of Turku
Cell Trafficking in Cancer and Inflammation
Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery
![](https://drugdevelopment.fi/wp-content/uploads/2017/05/Mattila_Pieta-15.jpg)
Research Group:
B lymphocyte activation and the role of the cytoskeleton in health and disease
Pieta Mattila
pieta.mattila[at]utu.fi
Institute of Biomedicine,
University of Turku
Allergy, Antibodies, Autoimmune diseases, Basic research, Biomedicine, Cancer, Drug target, Imaging, Immunology, Infection, Inflammation, Inherited diseases, Molecular Cell Biology, Pathology, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery
![Picture of Matej Oresic](https://drugdevelopment.fi/wp-content/uploads/2017/06/Matej-Oresic-370x344.jpg)
Research Group:
Systems Medicine
Matej Oresic
matej.oresic[at]utu.fi
Turku Bioscience Centre,
University of Turku
Assay development, Autoimmune diseases, Bioinformatics, Biomarker, Diabetes, Diagnostics, Metabolic diseases, Metabolomics, Molecular diagnostics, Obesity, Personalized medicine, Systems Biology